VIVIAN MARCUZZO: Open Payments
NPI 1932215407 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 40 payments from 20 companies in 2025. Trend: 2023 $785 · 2024 $731 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $248 |
| Inspire Medical Systems, Inc. | 3 | $135 |
| Novo Nordisk Inc | 5 | $101 |
| ABBVIE INC. | 3 | $67 |
| Abbott Laboratories | 2 | $58 |
| Astellas Pharma US Inc | 2 | $56 |
| PFIZER INC. | 2 | $44 |
| Viatris Specialty LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Averitas Pharma Inc. | 1 | $26 |
Products named: KISUNLA, INSPIRE, FREESTYLE LIBRE 3, Veozah, JARDIANCE, Ozempic, REXULTI, PREVNAR 20.
Industry payments across AZ — which companies pay providers there.
